Medical Devices Hong Kong

Hong Kong Tuberculosis Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Hong Kong Tuberculosis Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Test, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Hong Kong · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $4.5 Mn Placeholder estimate
Estimate 2025 $4.8 Mn 0.2% of the global market
Projected 2034 $8.9 Mn 85.4% Adds $4.1 Mn over 9 forecast years
CAGR 2025–2034 7.1% Faster than 16% of 173 Medical Devices markets here
Key players 5
  • Hong Kong is 0.19% of the global market.
  • In APAC, the largest is China at $232.9 Mn.
  • Fastest growing: India at 9.1% a year.
  • Hong Kong ranks 7th of 10 by size in APAC.

Market size projection

Hong Kong

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$4.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Tuberculosis Diagnostics Market market size by year, Hong Kong
YearMarket sizeChange that yearSince 2025
2024 (estimate) $4.5 Mn — —
2025 (base) $4.8 Mn +$0.3 Mn —
2026 (forecast) $5.2 Mn +$0.3 Mn +7.1%
2027 (forecast) $5.5 Mn +$0.4 Mn +14.7%
2028 (forecast) $5.9 Mn +$0.4 Mn +22.8%
2029 (forecast) $6.3 Mn +$0.4 Mn +31.6%
2030 (forecast) $6.8 Mn +$0.5 Mn +40.9%
2031 (forecast) $7.3 Mn +$0.5 Mn +50.9%
2032 (forecast) $7.8 Mn +$0.5 Mn +61.6%
2033 (forecast) $8.3 Mn +$0.6 Mn +73.1%
2034 (forecast) $8.9 Mn +$0.6 Mn +85.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Hong Kong Tuberculosis Diagnostics Market Analysis at a glance
Market size, 2025$4.8 Mn placeholder estimate
Forecast, 2034$8.9 Mn placeholder estimate
Growth (CAGR), 2025–20347.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, setting and end user (see all)
Key playersCepheid, Qiagen N.V., Molbio Diagnostics, Qure.ai, Revvity (see all)
Regulator in Hong KongMDACSSource: Medical Device Division, Department of Health. Checked 14 Nov 2026.
Active clinical trials7 in Hong KongSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Hong Kong. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Hong Kong Tuberculosis Diagnostics Market Analysis Executive Summary

Tuberculosis diagnostics find TB infection and disease using skin tests, blood tests, molecular tests and chest X-ray reading.

Key segments of the tuberculosis Diagnostics market include test (Molecular Tests, Interferon Gamma Release Assays and Skin Tests) and setting (Hospitals, TB Programs and Point of Care).

Bar chart: Hong Kong Tuberculosis Diagnostics market size, 2024–2034, placeholder estimates. $4.5 Mn in 2024, $4.8 Mn in 2025 and $8.9 Mn in 2034, 7.1% CAGR.
Hong Kong Tuberculosis Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Hong Kong Tuberculosis Diagnostics Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the tuberculosis Diagnostics market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the tuberculosis Diagnostics market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the tuberculosis Diagnostics market.

Competitive Landscape for Tuberculosis Diagnostics Market in Hong Kong

The tuberculosis Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Tuberculosis Diagnostics Market in Hong Kong

Tuberculosis Diagnostics in Hong Kong: rules, payment and research

Hong Kong has a voluntary listing system for medical devices (MDACS), run by the Medical Device Division of the Department of Health.⁠[1] Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government.⁠[2] ClinicalTrials.gov lists 7 studies on Tuberculosis Diagnostics that are recruiting, active or about to start in Hong Kong.⁠[3] Tuberculosis new cases: 66 per 100,000 people in 2024, the latest WHO figure for Hong Kong.⁠[4]

[1] Medical Device Division, Department of Health. Checked 14 Nov 2026.

[2] Hospital Authority. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Hong Kong. Retrieved 12 Nov 2026.

[4] WHO Global Health Observatory, Tuberculosis new cases (per 100,000 people). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how tuberculosis Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Hong Kong.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Tuberculosis Diagnostics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Tuberculosis Diagnostics in context

Hong Kong compared

  • Tuberculosis new cases: 66 per 100,000 people (2024). World: 131 per 100,000 people (2024). 11th highest of the 16 countries we cover in APAC.[1]

[1] World Bank Open Data, Tuberculosis new cases (per 100,000 people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Tuberculosis Diagnostics market in Hong Kong?
Placeholder estimate: about $4.8 Mn in 2025, rising to about $8.9 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Tuberculosis Diagnostics market in Hong Kong growing?
Placeholder estimate: about 7.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Tuberculosis Diagnostics market report cover?
The report splits the market by test (Molecular Tests, Interferon Gamma Release Assays, Skin Tests, Sputum Smear and more), setting (Hospitals, TB Programs, Point of Care) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Tuberculosis Diagnostics market?
Key players include Cepheid, Qiagen N.V., Molbio Diagnostics, Qure.ai and Revvity.
What is driving the Tuberculosis Diagnostics market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the tuberculosis Diagnostics market.
Who regulates Tuberculosis Diagnostics in Hong Kong?
Hong Kong has a voluntary listing system for medical devices (MDACS), run by the Medical Device Division of the Department of Health. Source: Medical Device Division, Department of Health. Checked 14 Nov 2026.
How is healthcare paid for in Hong Kong?
Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government. Source: Hospital Authority. Checked 14 Nov 2026.
How many clinical trials on Tuberculosis Diagnostics are running in Hong Kong?
7 studies are recruiting, active or about to start in Hong Kong, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Hong Kong. Retrieved 12 Nov 2026.
What does WHO report for Hong Kong?
Tuberculosis new cases: 66 per 100,000 people in 2024, the latest WHO figure. Source: WHO Global Health Observatory, Tuberculosis new cases (per 100,000 people). Retrieved 15 Nov 2026.
How many people in Hong Kong are 65 or older?
23.7% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 16 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Hong Kong

See all

Related on diagnostics and lab testing and tuberculosis

See the topic